This Week in Addiction Medicine from ASAM
Health & Fitness:Medicine
Lead Story: Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder
Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder
JAMA Psychiatry
In this case-control study of 34,505 Medicare beneficiaries, patients had greater risk of experiencing an opioid overdose and higher health care expenditures in buprenorphine treatment gap months compared with treated months. Buprenorphine nonadherence is associated with an increased risk of opioid overdose and higher health care spending in Medicare.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
Create your
podcast in
minutes
It is Free